CPT® Code 87525

The CPT® Code 87525 refers to a laboratory test designed for the detection of the hepatitis G virus (HGV), also known as GB virus-C (GBV-C), through the use of nucleic acid techniques, specifically targeting DNA or RNA. This test employs a direct probe technique to identify the unique nucleic acid sequence of the hepatitis G virus present in a blood sample. HGV infections are often asymptomatic and do not typically lead to significant liver inflammation; however, they can occur alongside other viral infections that do cause acute or chronic hepatitis. The transmission of HGV primarily occurs through infected blood and blood products, from mother to infant during childbirth, and through sexual contact with an infected partner. The direct probe test utilizes a labeled probe that binds specifically to the target sequence of the hepatitis G virus, allowing for its detection if present in the sample. The probe is equipped with fluorescent or chemiluminescent labels, enhancing the visibility of the target sequence. The process involves treating the sample to release nucleic acids from the virus, followed by the formation of a stable hybrid between the probe and the target sequence. Ribosomal RNA is often the focus of these tests due to its abundance in microorganisms, which allows for more effective detection compared to genomic DNA. For enhanced sensitivity, an amplified probe technique (CPT® Code 87526) may be employed, which involves exponentially increasing the target sequence of the hepatitis G virus DNA or RNA prior to detection. This amplification is commonly achieved through polymerase chain reaction (PCR) or reverse transcriptase polymerase chain reaction (RT-PCR). Furthermore, nucleic acid detection with quantification (CPT® Code 87527) provides an assessment of the quantity of microorganisms present, utilizing quantitative or real-time PCR to generate detailed reports on the amounts of the detected nucleic acid sequences.